148 related articles for article (PubMed ID: 30929921)
21. Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 Pathway.
Yan P; Gong H; Zhai X; Feng Y; Wu J; He S; Guo J; Wang X; Guo R; Xie J; Li RK
Am J Pathol; 2016 Apr; 186(4):1015-24. PubMed ID: 26835537
[TBL] [Abstract][Full Text] [Related]
22. RPS24c Isoform Facilitates Tumor Angiogenesis
Wang Y; Wu Y; Xiao K; Zhao Y; Lv G; Xu S; Wu F
Curr Mol Med; 2020; 20(5):388-395. PubMed ID: 31797757
[TBL] [Abstract][Full Text] [Related]
23. Myocyte enhancer factor 2D promotes colorectal cancer angiogenesis downstream of hypoxia-inducible factor 1α.
Xiang J; Sun H; Su L; Liu L; Shan J; Shen J; Yang Z; Chen J; Zhong X; Ávila MA; Yan X; Liu C; Qian C
Cancer Lett; 2017 Aug; 400():117-126. PubMed ID: 28478181
[TBL] [Abstract][Full Text] [Related]
24. Pregnancy-specific glycoprotein 9 (PSG9), a driver for colorectal cancer, enhances angiogenesis via activation of SMAD4.
Yang L; Hu S; Tan J; Zhang X; Yuan W; Wang Q; Xu L; Liu J; Liu Z; Jia Y; Huang X
Oncotarget; 2016 Sep; 7(38):61562-61574. PubMed ID: 27528036
[TBL] [Abstract][Full Text] [Related]
25. Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2.
Hu HY; Yu CH; Zhang HH; Zhang SZ; Yu WY; Yang Y; Chen Q
Int J Biol Macromol; 2019 Jul; 132():470-477. PubMed ID: 30936013
[TBL] [Abstract][Full Text] [Related]
26. Identification of NCK1 as a novel downstream effector of STAT3 in colorectal cancer metastasis and angiogenesis.
Zhang F; Lu YX; Chen Q; Zou HM; Zhang JM; Hu YH; Li XM; Zhang WJ; Zhang W; Lin C; Li XN
Cell Signal; 2017 Aug; 36():67-78. PubMed ID: 28455144
[TBL] [Abstract][Full Text] [Related]
27. SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma.
Palomero J; Vegliante MC; Rodríguez ML; Eguileor A; Castellano G; Planas-Rigol E; Jares P; Ribera-Cortada I; Cid MC; Campo E; Amador V
Blood; 2014 Oct; 124(14):2235-47. PubMed ID: 25092176
[TBL] [Abstract][Full Text] [Related]
28. 15-Lipoxygenase-1 re-expression in colorectal cancer alters endothelial cell features through enhanced expression of TSP-1 and ICAM-1.
Tunçer S; Keşküş AG; Çolakoğlu M; Çimen I; Yener C; Konu Ö; Banerjee S
Cell Signal; 2017 Nov; 39():44-54. PubMed ID: 28757355
[TBL] [Abstract][Full Text] [Related]
29. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
[TBL] [Abstract][Full Text] [Related]
30. Progastrin a new pro-angiogenic factor in colorectal cancer.
Najib S; Kowalski-Chauvel A; Do C; Roche S; Cohen-Jonathan-Moyal E; Seva C
Oncogene; 2015 Jun; 34(24):3120-30. PubMed ID: 25109333
[TBL] [Abstract][Full Text] [Related]
31. MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis.
Zhou Q; Zhu Y; Wei X; Zhou J; Chang L; Sui H; Han Y; Piao D; Sha R; Bai Y
Cell Death Dis; 2016 Oct; 7(10):e2413. PubMed ID: 27735951
[TBL] [Abstract][Full Text] [Related]
32. CCR6 promotes tumor angiogenesis via the AKT/NF-κB/VEGF pathway in colorectal cancer.
Zhu CC; Chen C; Xu ZQ; Zhao JK; Ou BC; Sun J; Zheng MH; Zong YP; Lu AG
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):387-397. PubMed ID: 29097259
[TBL] [Abstract][Full Text] [Related]
33. Patrinia scabiosaefolia inhibits colorectal cancer growth through suppression of tumor angiogenesis.
Chen L; Liu L; Ye L; Shen A; Chen Y; Sferra TJ; Peng J
Oncol Rep; 2013 Sep; 30(3):1439-43. PubMed ID: 23820929
[TBL] [Abstract][Full Text] [Related]
34. LIFR promotes tumor angiogenesis by up-regulating IL-8 levels in colorectal cancer.
Wu HX; Cheng X; Jing XQ; Ji XP; Chen XZ; Zhang YQ; He YG; Liu K; Ye F; Sun HX; Gao HJ; Song ZJ; Wu H; Zhang XJ; Zhang T; Zhao R
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2769-2784. PubMed ID: 29751081
[TBL] [Abstract][Full Text] [Related]
35. [Expression of hUTP14a in non-small cell lung cancer].
Zhang CF; Liu Y; Lu M; DU XJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Feb; 51(1):145-150. PubMed ID: 30773559
[TBL] [Abstract][Full Text] [Related]
36. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
[TBL] [Abstract][Full Text] [Related]
37. Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
Qu H; Yin H; Yan S; Tao M; Xie Y; Chen W
Oncol Rep; 2016 May; 35(5):2927-35. PubMed ID: 26936485
[TBL] [Abstract][Full Text] [Related]
38. The Lymphangiogenic Factor CCBE1 Promotes Angiogenesis and Tumor Growth in Colorectal Cancer.
Ding W; Tang W; Zhi J
Curr Mol Med; 2022; 22(9):819-825. PubMed ID: 34819004
[TBL] [Abstract][Full Text] [Related]
39. Nonylphenol regulates TL1A through the AhR/HDAC2/HNF4α pathway in endothelial cells to promote the angiogenesis of colorectal cancer.
Zhang T; Ning WW; Zhang J; Xu FJ; Wang XQ; Li ZB; Xie M
Toxicol Appl Pharmacol; 2022 Feb; 436():115854. PubMed ID: 34974051
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast activation protein-α in tumor cells promotes colorectal cancer angiogenesis via the Akt and ERK signaling pathways.
Cao F; Wang S; Wang H; Tang W
Mol Med Rep; 2018 Feb; 17(2):2593-2599. PubMed ID: 29207091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
